Turning Complexity into Clarity with Quantum AI
We deliver quantum-powered discovery with clinical-grade security, validation, and workflow integration.
our approach
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
our approach
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
our approach
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
our approach
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
Our Approach
Clinical Trust
Interoperability
Security
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
Right tool, right layer: Quantum where it helps, classical where it wins.
One spine: Shared data plane across imaging, omics, and design.
From bench to bedside: Built for real clinical and R&D workflows.
Our Approach
Clinical Trust
Interoperability
Security
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
Right tool, right layer: Quantum where it helps, classical where it wins.
One spine: Shared data plane across imaging, omics, and design.
From bench to bedside: Built for real clinical and R&D workflows.
Our Approach
Clinical Trust
Interoperability
Security
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
Right tool, right layer: Quantum where it helps, classical where it wins.
One spine: Shared data plane across imaging, omics, and design.
From bench to bedside: Built for real clinical and R&D workflows.
Our Approach
Clinical Trust
Interoperability
Security
We pair quantum search with HPC and applied AI to turn raw signals into decisions - end to end, not point solutions.
Right tool, right layer: Quantum where it helps, classical where it wins.
One spine: Shared data plane across imaging, omics, and design.
From bench to bedside: Built for real clinical and R&D workflows.
Our Mission
Advance care by combining quantum and AI to turn biological data into decisions that are faster, safer, and proven.
Our Mission
Advance care by combining quantum and AI to turn biological data into decisions that are faster, safer, and proven.
Our Mission
Advance care by combining quantum and AI to turn biological data into decisions that are faster, safer, and proven.
Our Mission
Advance care by combining quantum and AI to turn biological data into decisions that are faster, safer, and proven.
See Earlier
We surface subtle signals in imaging and multi-omics so clinicians can act before problems escalate.
See Earlier
We surface subtle signals in imaging and multi-omics so clinicians can act before problems escalate.
See Earlier
We surface subtle signals in imaging and multi-omics so clinicians can act before problems escalate.
See Earlier
We surface subtle signals in imaging and multi-omics so clinicians can act before problems escalate.
Predict Better
Calibrated models translate risk into clear next steps - who responds, who doesn’t, and what to do now.
Predict Better
Calibrated models translate risk into clear next steps - who responds, who doesn’t, and what to do now.
Predict Better
Calibrated models translate risk into clear next steps - who responds, who doesn’t, and what to do now.
Predict Better
Calibrated models translate risk into clear next steps - who responds, who doesn’t, and what to do now.
Design Smarter
Simulation narrows chemical space to higher-probability candidates, accelerating R&D without cutting rigor.
Design Smarter
Simulation narrows chemical space to higher-probability candidates, accelerating R&D without cutting rigor.
Design Smarter
Simulation narrows chemical space to higher-probability candidates, accelerating R&D without cutting rigor.
Design Smarter
Simulation narrows chemical space to higher-probability candidates, accelerating R&D without cutting rigor.
Why partner with QuantumDance?
Why partner with QuantumDance?
Why partner with QuantumDance?
Why partner with QuantumDance?
Measurable Outcomes
Measurable Outcomes
Measurable Outcomes
Measurable Outcomes
Faster cycles, clearer signals. We shorten analysis time while lifting accuracy, so teams move from exploration to decisions without the guesswork.
Benchmarks are published and reproducible. Methods, cohorts, and metrics are transparent, so wins stand up to clinical and scientific scrutiny.
Plugs into your workflow
Plugs into your workflow
Plugs into your workflow
Plugs into your workflow
No re-plumbing. We meet your stack - PACS/EHR, data lakes, cloud or on-prem, with standards-based APIs and clean rollout paths.
Security is built in. PHI-safe pipelines, least-privilege access, and audit-ready logging keep governance simple and stakeholders confident.
Built with you, for you
Built with you, for you
Built with you, for you
Built with you, for you
Co-development over hand-offs. Clinicians, scientists, and engineers work shoulder-to-shoulder to fit real workflows, not ideal ones.
Long-term partnership. Clear roadmaps, dedicated support, and measurable milestones - so value compounds after day one.
Our Process
The road to validated outcomes
Our Process
The road to validated outcomes
Our Process
The road to validated outcomes
Our Process
The road to validated outcomes
01
Define goals & guardrails
We start with a working session to nail the problem, the success metrics, and the constraints that matter - clinical, technical, and regulatory. Together we select the first use case, agree on measurable KPIs, and outline the data we’ll need (imaging, omics, or assay outputs). We document ownership, timeline, and a clear decision cadence, so everyone knows who does what, by when, and how we’ll judge progress.
01
Define goals & guardrails
We start with a working session to nail the problem, the success metrics, and the constraints that matter - clinical, technical, and regulatory. Together we select the first use case, agree on measurable KPIs, and outline the data we’ll need (imaging, omics, or assay outputs). We document ownership, timeline, and a clear decision cadence, so everyone knows who does what, by when, and how we’ll judge progress.
01
Define goals & guardrails
We start with a working session to nail the problem, the success metrics, and the constraints that matter - clinical, technical, and regulatory. Together we select the first use case, agree on measurable KPIs, and outline the data we’ll need (imaging, omics, or assay outputs). We document ownership, timeline, and a clear decision cadence, so everyone knows who does what, by when, and how we’ll judge progress.
01
Define goals & guardrails
We start with a working session to nail the problem, the success metrics, and the constraints that matter - clinical, technical, and regulatory. Together we select the first use case, agree on measurable KPIs, and outline the data we’ll need (imaging, omics, or assay outputs). We document ownership, timeline, and a clear decision cadence, so everyone knows who does what, by when, and how we’ll judge progress.
02
Prepare data & prototype
We establish secure access (BAA as needed), set up connectors to your PACS/EHR or data lake, and run a quick data readiness pass to confirm coverage and quality. With that in place, we build a prototype against your cohorts, benchmarked against current workflows to show lift where it counts. You preview results in a controlled sandbox, give feedback on fit and usability, and we tighten the loop until it works in the way your team actually operates.
02
Prepare data & prototype
We establish secure access (BAA as needed), set up connectors to your PACS/EHR or data lake, and run a quick data readiness pass to confirm coverage and quality. With that in place, we build a prototype against your cohorts, benchmarked against current workflows to show lift where it counts. You preview results in a controlled sandbox, give feedback on fit and usability, and we tighten the loop until it works in the way your team actually operates.
02
Prepare data & prototype
We establish secure access (BAA as needed), set up connectors to your PACS/EHR or data lake, and run a quick data readiness pass to confirm coverage and quality. With that in place, we build a prototype against your cohorts, benchmarked against current workflows to show lift where it counts. You preview results in a controlled sandbox, give feedback on fit and usability, and we tighten the loop until it works in the way your team actually operates.
02
Prepare data & prototype
We establish secure access (BAA as needed), set up connectors to your PACS/EHR or data lake, and run a quick data readiness pass to confirm coverage and quality. With that in place, we build a prototype against your cohorts, benchmarked against current workflows to show lift where it counts. You preview results in a controlled sandbox, give feedback on fit and usability, and we tighten the loop until it works in the way your team actually operates.
03
Validate, integrate, and scale
We formalize methods, lock metrics, and validate on holdout datasets—then integrate into the live workflow via standards-based APIs and role-appropriate views. Rollout happens in stages with change control, audit logging, and clear playbooks for monitoring, drift, and support. Once value is proven, we expand to additional sites or use cases, keeping the same rhythm: measurable outcomes, secure operations, and continuous improvement.
03
Validate, integrate, and scale
We formalize methods, lock metrics, and validate on holdout datasets—then integrate into the live workflow via standards-based APIs and role-appropriate views. Rollout happens in stages with change control, audit logging, and clear playbooks for monitoring, drift, and support. Once value is proven, we expand to additional sites or use cases, keeping the same rhythm: measurable outcomes, secure operations, and continuous improvement.
03
Validate, integrate, and scale
We formalize methods, lock metrics, and validate on holdout datasets—then integrate into the live workflow via standards-based APIs and role-appropriate views. Rollout happens in stages with change control, audit logging, and clear playbooks for monitoring, drift, and support. Once value is proven, we expand to additional sites or use cases, keeping the same rhythm: measurable outcomes, secure operations, and continuous improvement.
03
Validate, integrate, and scale
We formalize methods, lock metrics, and validate on holdout datasets—then integrate into the live workflow via standards-based APIs and role-appropriate views. Rollout happens in stages with change control, audit logging, and clear playbooks for monitoring, drift, and support. Once value is proven, we expand to additional sites or use cases, keeping the same rhythm: measurable outcomes, secure operations, and continuous improvement.
Impressive metrics
Impressive metrics
Impressive metrics
Impressive metrics
We publish how we measure lift: cohorts, splits, metrics, and benchmarks, so outcomes are reproducible, not anecdotal. Methods are documented and tied to real datasets, with results traced to specific workloads.
We publish how we measure lift: cohorts, splits, metrics, and benchmarks, so outcomes are reproducible, not anecdotal. Methods are documented and tied to real datasets, with results traced to specific workloads.
We publish how we measure lift: cohorts, splits, metrics, and benchmarks, so outcomes are reproducible, not anecdotal. Methods are documented and tied to real datasets, with results traced to specific workloads.
We publish how we measure lift: cohorts, splits, metrics, and benchmarks, so outcomes are reproducible, not anecdotal. Methods are documented and tied to real datasets, with results traced to specific workloads.
Imaging: up to 99.7% accuracy and ~90× faster reconstruction/triage on internal benchmarks.
Imaging: up to 99.7% accuracy and ~90× faster reconstruction/triage on internal benchmarks.
Imaging: up to 99.7% accuracy and ~90× faster reconstruction/triage on internal benchmarks.
Imaging: up to 99.7% accuracy and ~90× faster reconstruction/triage on internal benchmarks.
Genomics: whole-genome processing in ~30 minutes, about 48× faster than baseline.
Genomics: whole-genome processing in ~30 minutes, about 48× faster than baseline.
Genomics: whole-genome processing in ~30 minutes, about 48× faster than baseline.
Genomics: whole-genome processing in ~30 minutes, about 48× faster than baseline.
Binding & redesign: 1000× exploration speedups with ~95% binding-prediction accuracy in internal tests.
Binding & redesign: 1000× exploration speedups with ~95% binding-prediction accuracy in internal tests.
Binding & redesign: 1000× exploration speedups with ~95% binding-prediction accuracy in internal tests.
Binding & redesign: 1000× exploration speedups with ~95% binding-prediction accuracy in internal tests.
External traction: 3 pharma LOIs and 10 hospital pilots in flight to expand cohorts and prospective validation.
External traction: 3 pharma LOIs and 10 hospital pilots in flight to expand cohorts and prospective validation.
External traction: 3 pharma LOIs and 10 hospital pilots in flight to expand cohorts and prospective validation.
External traction: 3 pharma LOIs and 10 hospital pilots in flight to expand cohorts and prospective validation.
* Add any required disclaimer text for the claims made above using this small fine-print text.
Our people
Our people
Our people
Our people
Leadership Team
Leadership
Team
Leadership Team
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
Confidential Material
This section contains proprietary information intended for potential investors,
Confidential Material
This section contains proprietary information intended for potential investors,
Confidential Material
This section contains proprietary information intended for potential investors,
Confidential Material
This section contains proprietary information intended for potential investors,
Frequently Asked Questions
Frequently Asked Questions
Frequently Asked Questions
Frequently Asked Questions
Everything you need to know about accelerating discovery with quantum algorithms.
Everything you need to know about accelerating discovery with quantum algorithms.
Everything you need to know about accelerating discovery with quantum algorithms.
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
How is quantum different from classical methods?
Our hybrid quantum-classical architecture explores chemical space exponentially faster. CTSim's quantum algorithms simulate millions of molecular interactions simultaneously, while classical tools process sequentially. Results: promising drug candidates identified in days versus months, with superior binding affinity predictions and early liability detection.
What systems does the platform integrate with?
How accurate are the biomarker predictions?
How do you handle confidential data?
What's the typical timeline for results?
What technical expertise is needed?
Impressive metrics
Latest News
Impressive metrics
Latest News
Impressive metrics
Latest News
Impressive metrics
